North America DVT Preventive Pump Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Lower Extremity and Upper Extremity) and End User (Hospitals and Clinics, Surgical Centers, and Others)

North America DVT Preventive Pump Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Lower Extremity and Upper Extremity) and End User (Hospitals and Clinics, Surgical Centers, and Others)

The North America DVT preventive pump market is expected to grow from US$ 159.01 million in 2022 to US$ 209.64 million by 2028; it is estimated to record a CAGR of 4.7% from 2022 to 2028.

Rising Cases of Cardiac Disorders and Stroke Favor North America DVT Preventive Pump Market Growth

Cardiovascular diseases (CVDs) are one of the leading causes of death in North America. People from low- and middle-income countries in North America suffer from noncommunicable diseases such as CVDs, as they have minimal access to effective and equitable health services. Moreover, patients with cardiac diseases are at a significantly higher risk of heart disease and stroke than the general population, which can lead to the development of deep vein thrombosis (DVT). The incidence of heart failure and atrial fibrillation is twice among patients with coronary artery disease, which, in turn, contributes to the prevalence of DVT. Stroke remains an immense concern for public health authorities, regardless of advancements made for understanding several factors associated with the condition, including epidemiology, quality of life, and pathophysiology. Per the American Heart Association, stroke is the fifth-highest cause of death in the US, resulting in 1 in 6 deaths in 2020. In 2019, the US registered 460,000 stroke cases (two-thirds were ischemic), out of which 190,000 cases resulted in deaths and 3.83 million cases led to stroke-disability-adjusted life years. Therefore, the rising cases of cardiac disorders and stroke are boosting the prevalence of DVT in North America, thereby driving the growth of the North America DVT preventive pump market .

North America DVT Preventive Pump Market Overview

The North America DVT preventive pump market is segmented into the US, Canada, and Mexico. The market growth in this region is attributed to technological advancements related to the treatment of DVT. The US was the first country that approved an interventional device for the treatment of pulmonary embolism. It is a safe, repeatable, and reliable treatment that dissolves thrombus quickly, with low lytic, and less blood loss and trauma. It uses ultrasonic care technology, which is a minimally invasive method that is completed within 15 minutes.

North America DVT preventive pump Market Revenue and Forecast to 2028 (US$ Million)

North America DVT preventive pump Market Segmentation

The North America DVT preventive pump market is segmented on the basis of service type, end user, and country.

Based on type, the North America DVT preventive pump market is bifurcated into lower extremity and upper extremity. The lower extremity testing segment held a larger market share in 2022.

The North America DVT preventive pump market, by end user, is segmented into hospitals and clinics, surgical centers, and others. The hospitals and clinics segment held the largest market share in 2022.

In terms of country, the North America DVT preventive pump market is segmented into the US, Canada, and Mexico. The US dominated the market in this region in 2022.

Devo Medical Products Inc., Breg Inc., Bio Compression Systems Inc., Cardinal Health Inc., Arjo AB, Mego Afek Ltd., DJO LLC, Currie Medical Specialities Inc., Zimmer Biomet Holdings Inc., and ThermoTek Inc. are among the leading companies operating in the North America DVT preventive pump market.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America DVT preventive pump market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the North America DVT preventive pump market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the North America DVT preventive pump market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution